Teeft.i
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration MERS - Checkpoint (Istex)

Index « Teeft.i » - entrée « Antisense oligonucleotide »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antisense oligomers < Antisense oligonucleotide < Antisense oligonucleotide analog  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000D62 (2002) Phillip C. C. Liu [États-Unis] ; Maria J. Moreno-Aliaga [États-Unis] ; Debra Y. Dunlap [États-Unis] ; Xiao-Ming Hu [États-Unis] ; Michael S. Denison [États-Unis] ; Fumio Matsumura [États-Unis]Correlation between the high expression of C/EBPβ protein in F442A cells and their relative resistance to antiadipogenic action of TCDD in comparison to 3T3‐L1 cells
000E13 (2001) Tumor necrosis factor- α is required for cholestasis-induced liver fibrosis in the mouse
000E36 (2001) Single-stranded oligonucleotides can mediate site-specific nucleotide conversion in cultured cells and in utero
000E37 (2001) Sequence-specific cleavage of HCV RNA by the modified ribonuclease H conjugated to HCV antisense oligodeoxynucleotides
000E84 (2001) Flt3-ligand in combination with CD40-ligand gene transfer following radiation-incudible HSV-TK gene therapy improves survival in mice with diffuse hepatocellular carcinoma
000F53 (2000) C. A Stein [États-Unis]Is irrelevant cleavage the price of antisense efficacy?
001171 (1999) S. Patrick Walton [États-Unis] ; Gregory N. Stephanopoulos [États-Unis] ; Martin L. Yarmush [États-Unis] ; Charles M. Roth [États-Unis]Prediction of antisense oligonucleotide binding affinity to a structured RNA target
001234 (1998) A. Kirk Field [États-Unis]Viral targets for antisense oligonucleotides: a mini review
001359 (1998) Mario C. Filion [Canada] ; Nigel C. Phillips [Canada]Major limitations in the use of cationic liposomes for DNA delivery
001420 (1997) H. K Tewary [États-Unis] ; P. L Iversen [États-Unis]Qualitative and quantitative measurements of oligonucleotides in gene therapy: Part I in vitro models
001434 (1997) Włodzimierz Buczko [Pologne] ; Czesław Cierniewski [Pologne] ; Anna Kobyla Ska [Pologne] ; Maria Koziołkiewicz [Pologne] ; And Rzej Okruszek [Pologne] ; Zofia Pawłowska [Pologne] ; Elzbzieta Pluskota [Pologne] ; Wojciech J. Stec [Pologne]Modulation of plasminogen activator inhibitor type-1 biosynthesis in vitro and in vivo with oligo(nucleoside phosphorothioate)s and related constructs
001566 (1997) Dm Harnois [États-Unis] ; Fg Que [États-Unis] ; A. Celli [États-Unis] ; Nf Larusso [États-Unis] ; Gj Gores [États-Unis]Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line
001587 (1996) Jj Toulmé [France] ; R. Le Tinévez [France] ; E. Brossalina [France]Targeting RNA structures by antisense oligonucleotides
001788 (1995) Claudine Boiziau [France] ; Françoise Debart [France] ; Bernard Rayner [France] ; Jean-Louis Imbach [France] ; Jean-Jacques Toulme [France]Chimeric alpha-beta oligonucleotides as antisense inhibitors of reverse transcription
001790 (1995) Maura Buttiglione [Italie] ; Giuseppina Cangiano [Italie] ; Christo Goridis [France] ; Gianfranco Gennarini [Italie, France]Characterization of the 5′ and promoter regions of the gene encoding the mouse neuronal cell adhesion molecule F3
001795 (1995) Gerald Zon [États-Unis]Antisense phosphorothioate oligodeoxynucleotides: introductory concepts and possible molecular mechanisms of toxicity
001904 (1995) Gerald Zon [États-Unis]Brief overview of control of genetic expression by antisense oligonucleotides and in vivo applications
001961 (1994) Emanuelle Pascolo [France] ; Denis Hudrisier [France] ; Brian Sproat [Allemagne] ; Nguyen T. Thuong [France] ; Jean-Jacques Toulme [France]Relative contribution of photo-addition, helper oligonucleotide and RNase H to the antisense effect of psoralen-oligonucleotide conjugates, on in vitro translation of Leishmania mRNAs
001995 (1994) C. HélèneControl of oncogene expression by antisense nucleic acids
001A02 (1994) Alex J. Baertschi [États-Unis]Antisense oligonucleotide strategies in physiology
001B17 (1994) K. Sainio [Finlande] ; M. Saarma [Finlande] ; D. Nonclercq [Finlande] ; L. Paulin [Finlande] ; H. Sariola [Finlande]Antisense inhibition of low-affinity nerve growth factor receptor in kidney cultures: Power and pitfalls

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Antisense oligonucleotide" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Antisense oligonucleotide" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Antisense oligonucleotide
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021